Pelthos Therapeutics Inc. (PTHS)
NYSEAMERICAN: PTHS · Real-Time Price · USD
24.97
+0.20 (0.81%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Pelthos Therapeutics Analyst Ratings
Total Analysts
6
Consensus Rating
Strong Buy
Price Target
$54.17
Upside
+116.94%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Initiates $50 | Buy | Initiates | $50 | +100.24% | Apr 1, 2026 |
| Oppenheimer | Oppenheimer | Buy Maintains $60 → $62 | Buy | Maintains | $60 → $62 | +148.30% | Mar 20, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $60 | Strong Buy | Reiterates | $60 | +140.29% | Mar 19, 2026 |
| Piper Sandler | Piper Sandler | Buy Initiates $48 | Buy | Initiates | $48 | +92.23% | Feb 27, 2026 |
| Roth Capital | Roth Capital | Strong Buy Maintains $57 → $55 | Strong Buy | Maintains | $57 → $55 | +120.26% | Feb 26, 2026 |
| Oppenheimer | Oppenheimer | Buy Maintains $57 → $60 | Buy | Maintains | $57 → $60 | +140.29% | Jan 26, 2026 |
| Lake Street | Lake Street | Strong Buy Initiates $50 | Strong Buy | Initiates | $50 | +100.24% | Dec 3, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $60 | Strong Buy | Initiates | $60 | +140.29% | Dec 3, 2025 |
| Roth Capital | Roth Capital | Strong Buy Initiates $57 | Strong Buy | Initiates | $57 | +128.27% | Nov 25, 2025 |
| Oppenheimer | Oppenheimer | Buy Reiterates $50 → $57 | Buy | Reiterates | $50 → $57 | +128.27% | Nov 14, 2025 |
| Oppenheimer | Oppenheimer | Buy Initiates $50 | Buy | Initiates | $50 | +100.24% | Sep 2, 2025 |